BI
KURA icon

BVF Inc’s Kura Oncology KURA Stock Holding History

BVF Inc’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$68.7M Sell
8,445,769
-171,393
-2% -$1.47M 2.19% 19
2025
Q4 		$89.5M Hold
8,617,162
– – 3.01% 11
2025
Q3 		$76.3M Buy
8,617,162
+863,033
+11% +$6.15M 3.09% 10
2025
Q2 		$44.7M Hold
7,754,129
– – 1.6% 13
2025
Q1 		$51.2M Buy
7,754,129
+5,186,660
+202% +$40.4M 2.09% 11
2024
Q4 		$22.4M Sell
2,567,469
-804,292
-24% -$11.6M 0.76% 27
2024
Q3 		$65.9M Sell
3,371,761
-710,276
-17% -$14.4M 1.93% 15
2024
Q2 		$84M Sell
4,082,037
-704,256
-15% -$14.5M 2.36% 12
2024
Q1 		$102M Sell
4,786,293
-2,586,935
-35% -$50.3M 2.81% 11
2023
Q4 		$106M Buy
7,373,228
+642,245
+10% +$6.32M 2.65% 9
2023
Q3 		$61.4M Hold
6,730,983
– – 1.66% 17
2023
Q2 		$71.2M Hold
6,730,983
– – 1.98% 14
2023
Q1 		$82.3M Buy
6,730,983
+2,930,000
+77% +$36.6M 3.01% 8
2022
Q4 		$47.2M Buy
3,800,983
+597,200
+19% +$8.68M 1.99% 17
2022
Q3 		$43.8M Hold
3,203,783
– – 1.81% 18
2022
Q2 		$58.7M Hold
3,203,783
– – 2.84% 11
2022
Q1 		$51.5M Buy
3,203,783
+1,139,571
+55% +$16.5M 2.06% 14
2021
Q4 		$28.9M Buy
2,064,212
+429,100
+26% +$6.95M 1.05% 28
2021
Q3 		$30.6M Hold
1,635,112
– – 1.19% 22
2021
Q2 		$34.1M Hold
1,635,112
– – 1.28% 20
2021
Q1 		$46.2M Buy
1,635,112
+389,200
+31% +$12.3M 1.73% 18
2020
Q4 		$40.7M Sell
1,245,912
-243,200
-16% -$8.55M 1.6% 21
2020
Q3 		$45.6M Sell
1,489,112
-1,286,770
-46% -$28.4M 2.48% 12
2020
Q2 		$45.2M Buy
2,775,882
+341,186
+14% +$4.92M 2.79% 14
2020
Q1 		$24.2M Buy
2,434,696
+436,420
+22% +$5M 2.26% 14
2019
Q4 		$27.5M Hold
1,998,276
– – 2.08% 15
2019
Q3 		$30.3M Sell
1,998,276
-205,843
-9% -$3.66M 3.19% 11
2019
Q2 		$43.4M Sell
2,204,119
-291,037
-12% -$4.83M 4.74% 6
2019
Q1 		$41.4M Sell
2,495,156
-280,000
-10% -$4.31M 4.64% 4
2018
Q4 		$39M Buy
2,775,156
+759,300
+38% +$10.1M 5.09% 4
2018
Q3 		$35.3M Sell
2,015,856
-41,490
-2% -$795K 3.1% 8
2018
Q2 		$37.4M Buy
2,057,346
+703,500
+52% +$11.9M 3.65% 7
2018
Q1 		$25.4M Hold
1,353,846
– – 2.57% 14
2017
Q4 		$20.7M Hold
1,353,846
– – 2.5% 13
2017
Q3 		$20.2M Buy
+1,353,846
New +$12.7M 2.57% 13

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

BVF Inc's KURA Position: Q1 2026 in Review

BVF Inc reduced its Kura Oncology (KURA) stake by 2% in Q1 2026, selling an estimated $1.47M and leaving 8,445,769 shares worth $68.7M. The position accounts for 2.19% of the portfolio, ranked #19.

BVF Inc first reported a position in KURA in Q3 2017 and has held it in 35 quarters since. The position peaked at $106M in Q4 2023. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • BVF Inc held 8,445,769 shares of Kura Oncology worth $68.7M as of Q1 2026.
  • BVF Inc sold 171,393 Kura Oncology shares in Q1 2026, an estimated $1.47M.
  • Kura Oncology made up 2.19% of BVF Inc's portfolio in Q1 2026, its #19 holding.
  • BVF Inc first reported a position in Kura Oncology in Q3 2017 and has held it in 35 quarters since.
  • BVF Inc's Kura Oncology position peaked at $106M in Q4 2023.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on BVF Inc's 13F filing for Q1 2026, filed 15 May 2026.